Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on June 15, 2022. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Search

Top

Back to Contracts

2 PAM Autoinjectors

Closed

2PAMAI-BARDA-2022Federal

Submission Closed07/01/2022, 04:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

NAICS

N/A

Place of Performance

DC

Set-Aside

NONE

Documents

1

PBS_2PAMAI_FY22_Pre-Sol_V2.pdf

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed

PostedJun 15

Presolicitation

Response DeadlineJul 1

Deadline has passed

Submission Closed

07/01/2022, 04:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

Contacts2 people available

OfficeWASHINGTON, DC, 20515, USA

Organization / AgencyDepartment Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

Office AddressWASHINGTON, DC, 20515, USA

Contacts

Jennifer Taranto

contact@example.gov

Jonathan Gonzalez

contact@example.gov

Full Description

Show more

This acquisition will allow BARDA to invest Project Bioshield funds for late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.

More opportunities from Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

Same awarding agency

PHI Cybersecurity ImplementationThe PHI Cybersecurity Implementation subcontract, issued by the Department of Health and Human Services under BARDA, focuses on establishing robust cybersecurity frameworks to protect sensitive patient health information for medical device projects. The scope of work includes the deployment of secure cloud infrastructure, encryption protocols, and secure data transmission systems to ensure safe medical device connectivity. The selected provider will deliver a comprehensive secure data management system and a final cybersecurity certification. Strict adherence to regulatory and technical standards is required, specifically HIPAA compliance, NIST SP 800-53, and HITRUST standards. This opportunity falls under NAICS code 541512 and is based in Washington. Interested parties must submit their responses by November 18, 2026.

Computer Systems Design Services

POSTED

DEADLINE

Medical Device Logistics and Surge DistributionThis subcontract for Medical Device Logistics and Surge Distribution supports prime contractors on BARDA medical device projects under the Department of Health and Human Services. The scope of work involves comprehensive warehousing, inventory management, and the rapid distribution of medical devices to hospitals and emergency departments. A critical component of the contract is the management of surge capacity for mass casualty events, utilizing climate-controlled facilities and medical-grade logistics software to ensure efficient delivery to designated care settings. To ensure safety and regulatory adherence, the provider must maintain strict compliance with Good Distribution Practice and HIPAA standards. The project is categorized under NAICS code 493110 and is centered in Washington. Interested parties should note the response deadline of November 18, 2026.

General Warehousing and Storage

POSTED

DEADLINE

Medical-Grade Raw Material SupplyThis subcontract, titled Medical-Grade Raw Material Supply, involves the sourcing, quality testing, and delivery of essential raw materials used in the production of trauma and fracture-management devices. Supporting prime contractors on BARDA medical device projects under the Department of Health and Human Services, the scope of work focuses on providing medical-grade titanium, stainless steel, and specialized polymers. To ensure safety and efficacy, the contractor must provide full material certifications and maintain strict compliance with medical grade purity standards. The project is associated with NAICS code 325211 and is designated for performance in Washington, with a response deadline set for November 18, 2026.

Plastics Material and Resin Manufacturing

POSTED

DEADLINE

Specialized Medical Component FabricationThis subcontract for Specialized Medical Component Fabrication involves the production of precision components for medical devices focused on trauma care and fracture stabilization. Working under prime contractors for BARDA projects within the Department of Health and Human Services, the selected provider will utilize precision CNC machining and molding to fabricate hardware from biocompatible polymers and medical-grade alloys. The contract requires strict adherence to FDA regulatory compliance and ISO 13485 certification to ensure the quality of the finished medical device components. Performance will take place in Washington, with a response deadline set for November 18, 2026.

Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

DEADLINE

Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture Detection

Solicitation # BARDA-FY27-10192026

The Center for Biomedical Advanced Research and Development Authority (BARDA) has issued Sources Sought Notice BARDA-FY27-10192026 to identify innovative medical countermeasure technologies for the rapid triage of musculoskeletal injuries, such as fractures and soft tissue injuries of extremities. This request for information is intended for planning and market research purposes to assess commercially available or nearing-commercial technologies that utilize Super Intelligence (SI) and machine learning for automated ultrasound-based fracture detection. The goal is to find standalone, point-of-care devices that can operate in emergency departments, urgent care centers, and austere field settings without relying on traditional imaging infrastructure like X-ray or CT scans. The desired technology must feature automated volumetric capture, 3D-rotatable modeling, and SI-enabled image processing that outperforms human imaging experts and has undergone FDA 510k clearance processes. BARDA is interested in ruggedized, portable units with sufficient battery life for disaster response, interoperability with electronic health record systems, and minimal training requirements for non-specialist operators. Potential acquisition strategies being explored include direct purchases, leases, or vendor-managed inventory arrangements. Interested small businesses and other than small business concerns under NAICS code 334510 must submit their capabilities statements by 1:00 p.m. Eastern Time on November 18, 2026. Submissions must include separate Technical and Business Representation sections, each limited to 10 pages in 12-point Times New Roman font, and be emailed to Justin Moore and Richard Hall. Responses should detail the company's manufacturing capabilities within the United States, regulatory maturity, supply chain resilience, and cybersecurity standards for handling sensitive patient health information.

Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

DEADLINE

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Solicitation # 75A50126R00001_RFP_NPIVS_27

The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. The primary objective is to maintain a permanent readiness posture and commercially sustainable warm-base production capacity for the rapid manufacture of vaccines, antigens, and adjuvants during public health emergencies. Selected contractors will be responsible for producing countermeasures against influenza and other viruses with pandemic potential, generating necessary analytical, nonclinical, clinical, and chemistry, manufacturing, and controls data for FDA submission, and preparing candidate vaccine viruses. To be eligible, offerors must demonstrate successful experience in influenza vaccine manufacturing, evidenced by holding a U.S. influenza vaccine license or having submitted a Biologics License Application to the FDA. The contract is structured as an IDIQ with a five-year base period and a five-year option, totaling a potential 120-month ordering period. Award decisions will be based on the Highest Technically Rated Offerors with a Fair and Reasonable Price methodology, with a critical requirement for offerors to achieve a High Confidence rating in capabilities. Key deliverables include the submission of comprehensive manufacturing and supply chain continuity plans, surge readiness assessments, and strict adherence to CGMP guidelines and ASPR security requirements. Performance is monitored through a BARDA dose tracker, and final acceptance is contingent upon the submission of final reports and verified temperature control documentation during delivery. Invoicing is conducted quarterly via the Department of Treasury Invoice Processing Platform.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 1 month ago

DEADLINE

Vaccine Lot Production (Research, Investigational, and Commercial)This subcontract involves the production of influenza vaccine antigens and vaccines across research, investigational, and commercial bulk scales to support prime contractors on BARDA pandemic preparedness projects. The work is performed within cGMP compliant facilities to ensure all investigational and commercial lots meet strict regulatory alignment and quality standards. Managed by the Department of Health and Human Services under the Barda agency, the contract focuses on delivering bulk vaccine lots across three distinct production scales. The opportunity is categorized under NAICS code 325412, with a response deadline set for October 30, 2026, and performance based in Washington.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

cGMP Vaccine Seed Lot ManufacturingThis subcontract for cGMP Vaccine Seed Lot Manufacturing involves the production of yield-optimized Master Virus Seed, Working Virus Seed lots, or bacterial cell banks to support BARDA pandemic preparedness projects. The work is performed for prime contractors using qualified CVV reference strains within cGMP certified facilities that align with FDA-licensed vaccines or submitted BLAs. All seeds are characterized according to qualified internal standard operating procedures to ensure the delivery of certified lots. Managed by the Department of Health and Human Services under Barda, the contract falls under NAICS code 325412. The performance location is based in Washington, DC, with a response deadline of October 30, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Candidate Vaccine Virus (CVV) Development & CharacterizationThis subcontract, titled Candidate Vaccine Virus Development and Characterization, supports BARDA pandemic preparedness projects by preparing and characterizing both non-GLP and GLP influenza Candidate Vaccine Viruses. The scope of work includes performing HA/NA sequencing, genetic stability testing, ferret pathogenicity, two-way antigenicity, HA titer, sterility, and exclusivity. Additionally, the contractor is responsible for conducting plaque assays and chicken embryo lethality for HPAI strains within a BSL-2 environment, culminating in the delivery of final reports and Certificates of Analysis or Compliance. Managed by the Department of Health and Human Services under the Barda - Aspr agency, the project is categorized under NAICS code 541714. The performance location is based in Washington, DC. The solicitation was posted on August 17, 2026, with a response deadline set for October 30, 2026.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Specialized Material Supply (Vials, Stoppers, Seals)This subcontract for Specialized Material Supply focuses on providing critical medical-grade components, including vials, stoppers, seals, and crimps, to support prime contractors on BARDA pandemic preparedness projects. The scope of work requires the delivery of physical inventory and the provision of comprehensive supply chain narratives that detail the country of origin and tariff exposure for all containment and closure materials. Managed by the Department of Health and Human Services under the agency Barda - Aspr / Daappo / Barda Dcma, the contract is categorized under NAICS code 326199. The place of performance is located in Washington, DC, with a response deadline set for October 30, 2026.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Labeling, Packaging, and Cold Chain StorageThis subcontract, managed by the Department of Health and Human Services under BARDA, focuses on providing essential labeling, packaging, and specialized stability storage for bulk and final vaccine products. The scope of work involves supporting prime contractors on pandemic preparedness projects by managing cold chain logistics and stability monitoring for commercial scale bulk antigens, final containers, and bulk adjuvants. The contractor is responsible for the delivery of packaged products and the provision of detailed stability reports. This opportunity is categorized under NAICS code 493110 and is based in Washington, DC. The response deadline for this requirement is October 30, 2026.

General Warehousing and Storage

POSTED

DEADLINE

Formulation, Filling, and Finishing ServicesThis subcontract for Formulation, Filling, and Finishing Services supports BARDA pandemic preparedness projects by providing final formulation and filling of antigens, adjuvants, or co-formulated products into final containers. The work is performed under cGMP compliant processes within sterile filling environments to ensure the delivery of high-quality filled vials and containers for prime contractors. The opportunity is managed by the Department of Health and Human Services under the Barda - Aspr / Daappo / Barda Dcma agency and is categorized under NAICS code 325412. The project is based in Washington, DC, with a response deadline of October 30, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS